Evaluation of RUNX2 and HMGB1 expression as markers of tumor aggressiveness in urothelial carcinoma
Author:
Publisher
Medknow
Subject
General Earth and Planetary Sciences,General Environmental Science
Reference41 articles.
1. Abdelzaher E, Kotb AF (2016). High coexpression of runt-related transcription factor 2 (RUNX2) and p53 independently predicts early tumor recurrence in bladder urothelial carcinoma patients. Appl Immunohistochem Mol Morphol 24:345–354.
2. Amornsupak K, Jamjuntra P, Warnnissorn M, Pornchai O, Sa-Nguanraksa D, Thuwajit P, Thuwajit C (2017). High ASMA+ fibroblasts and low cytoplasmic HMGB1+ breast cancer cells predict poor prognosis. Clin Breast Cancer 17:441–452.
3. Boustead GB, Fowler S, Swamy R, Kocklebergh R, Hounsome L, Section of Oncology, BAUS (2014). Stage, grade and pathological characteristics of bladder cancer in the UK: British Association of Urological Surgeons (BAUS) Urological Tumour Registry. BJU Int 113:924–930.
4. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A (2020). Erratum: global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 70:313.
5. Chang SS, Boorjian SA, Chou R, Clark PE, Daneshmand S, Konety BR, et al. (2016). Diagnosis and treatment of non-muscle invasive bladder cancer: AUA/SUO guideline. J Urol 196:1021–1029.
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3